
|Videos|July 19, 2018
Managing Metastatic NSCLC With Rapid Progression
Managing Metastatic NSCLC With Rapid Progression
Advertisement
Case: A 53-Year-Old Woman with mNSCLC Rapid Progression
- A 53-year-old woman presents with a lump in her left deltoid and no other signs or symptoms
- PMH: insignificant, currently on no medications, no smoking history
- Chest X-ray showed a 5-cm soft tissue mass
- Biopsy showed advanced squamous cell carcinoma, TTF-1-
- Molecular testing negative for known actionable mutations
- PET CT revealed a liver lesion and adrenal mass
- Brain MRI showed no evidence of CNS metastasis
- Staging: T2aN3M1b
- 22C3 antibody testing; PD-L1 TPS, 0%
- The patient is started on cisplatin/gemcitabine
- Imaging at 3 months shows widespread progression with new and enlarging lesions including a significant increase in her soft tissue and lymph node disease, collapse of her right lower lobe and new liver lesions
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Oncologists Discuss IDH Inhibition Vs Chemo + RT for Grade 2 Glioma
2
ELEVATE Trial: Elacestrant Combos Boost PFS in ER+/HER2- Breast Cancer
3
Less Invasive Axillary Staging Is Noninferior to ALND in Post-NACT Node-Negative Breast Cancer
4
ctDNA: A Minimally Invasive Option for HR+ Breast Cancer Biomarker Testing
5






































